Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.

@article{Zanetti2010HepatitisBI,
  title={Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.},
  author={Alessandro Remo Zanetti and Luisa Roman{\`o} and Cristina Giambi and Anna Pavan and Vito Carnelli and Guglielmino Baitelli and Giancarlo Malchiodi and Edgardo Valerio and Antonella Barale and Maria Anna Marchisio and Domenico Mont{\`u} and Alberto E. Tozzi and Fortunato Paolo D'Ancona},
  journal={The Lancet. Infectious diseases},
  year={2010},
  volume={10 11},
  pages={755-61}
}
BACKGROUND In 2000, hexavac and infanrix hexa were licensed in Europe for primary immunisation of children against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive infections caused by Haemophilus influenzae b. In 2005, hexavac was suspended because of concerns about the long-term immunogenicity of its hepatitis B component. We aimed to assess the duration of immunity and need for booster injections in children primed with these vaccines. METHODS In an open-label… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

c conclusions and grounds for the suspension of the marketing authorisation of hexavac presented by the EMEA

  • U Heininger, R Sanger, JM Jacquet, L Schuerman
  • http://ema.europe.eu/humandocs/PDFs/EPAR/Hexavac…
  • 2010

Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPaHBVIPV / Hib in the fi rst and 2 nd year of life

  • M Steiner, G Ramakrishnan, B Gartner, O VanDerMeeren, JM Jacquet, V Schuster
  • Exp Rev Vaccines
  • 2009

Similar Papers

Loading similar papers…